医学
养生
放化疗
肿瘤科
阶段（地层学）
肺癌
内科学
护理标准
总体生存率
生物
古生物学
作者
Jiakang Li,Jingyan Xu,Mingyi Yang,Qing Zhou
标识
DOI：10.20892/j.issn.2095-3941.2022.0254
摘要
In the past, chemoradiotherapy (CRT) has been the standard of care for inoperable stage III NSCLC. Concurrent chemoradiotherapy (cCRT), if tolerable in patients, is the optimal treatment regimen. A meta-analysis has shown that cCRT results in a 5-year survival rate 4.5% longer than that with
科研通智能强力驱动
Strongly Powered by AbleSci AI
爱静静
寻道图强
丰盛的煎饼
加菲丰丰
杳鸢
shinysparrow
oceanao
竹筏过海
乐乐乐乐乐乐
YifanWang
西红柿炒番茄
贰鸟
Migue
ShowMaker
spark810
tianzml0
kento
田様
嗯哼
冒险寻羊
皖公网安备34019202002308
